| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 01/21/2010 | US20100015199 Method for suppressing generation of a teratoma |
| 01/21/2010 | US20100015198 Transplants encapsulated with self-elastic cartilage and method of preparing the same |
| 01/21/2010 | US20100015161 Composition Comprising In Vitro Expanded T-Lymphocytes and Vessel Formation Inhibitors Suitable in the Treatment of Cancer |
| 01/21/2010 | US20100015118 Supplement formula to prevent and deter muscle trauma and method of using same |
| 01/21/2010 | US20100015114 Peripheral-type benzodiazepine receptor expression level as an index of organ damage and regeneration |
| 01/21/2010 | US20100015113 Gp100-specific t cell receptors and related materials and methods of use |
| 01/21/2010 | US20100015112 Methods for the Induction of Professional and Cytokine-Producing Regulatory T Cells |
| 01/21/2010 | US20100015111 Methods And Kits For The Treatment Inhibition, And Maintenance Of Gastrointestinal Disorders |
| 01/21/2010 | US20100015110 Fermented milk for skin improvement and/or treatment and process for producing the same |
| 01/21/2010 | US20100015109 Composition for High-ORAC Value Dietary Supplement |
| 01/21/2010 | US20100015108 Methods for treating cancers and pathogen infections using antigen-presenting cells loaded with RNA |
| 01/21/2010 | US20100015107 Expression elements |
| 01/21/2010 | US20100015106 Method and compositions for inhibiting tumorigenesis |
| 01/21/2010 | US20100015105 Method of treating schizophrenia |
| 01/21/2010 | US20100015104 Generation of adipose tissue and adipocytes |
| 01/21/2010 | US20100015103 Cell culture method and application thereof |
| 01/21/2010 | US20100015102 Composition for treatment of cartilage disease |
| 01/21/2010 | US20100015101 Novel tumor antigen peptides |
| 01/21/2010 | US20100015100 Differentiation of human embryonic stem cells |
| 01/21/2010 | US20100015099 Materials and methods relating to treatment of injury and disease to the central nervous system |
| 01/21/2010 | US20100015098 Isolated phages and their use in food or pet food products |
| 01/21/2010 | US20100015097 Method of making sorbent, the sorbent obtained by this method and the uses of the sorbent as feed additive and medicine |
| 01/21/2010 | US20100015096 Fusion Proteins of Mycobacterium Tuberculosis |
| 01/21/2010 | US20100015095 Restoration of visual responses by in vivo delivery of rhodopsin nucleic acids |
| 01/21/2010 | US20100015086 Use of il-22 for the treatment of conditions of metabolic disorders |
| 01/21/2010 | CA2730612A1 Composition of branched maltodextrins and eukaryotic organisms having a polysaccharide wall, used in the field of well-being |
| 01/21/2010 | CA2730050A1 Composition comprising in vitro expanded t-lymphocytes and vessel formation inhibitors suitable in the treatment of cancer |
| 01/21/2010 | CA2729207A1 Composition of soluble indigestible fibre and of microalgae used in the well-being field |
| 01/21/2010 | CA2729072A1 Probiotic chewing gum method of manufacture |
| 01/21/2010 | CA2728830A1 Protein kinase inhibitors |
| 01/20/2010 | EP2145958A1 Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease |
| 01/20/2010 | EP2145629A2 Use of neurotoxin therapy for treatment of urologic and related disorders |
| 01/20/2010 | EP2144932A1 Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 |
| 01/20/2010 | EP2144672A1 A method for treating inflammation and controlled-release material capable of providing same |
| 01/20/2010 | EP2144618A1 Bioeffective krill oil compositions |
| 01/20/2010 | EP2144617A1 Delivery of flu antibodies to surfaces in contact with air |
| 01/20/2010 | EP1599227B1 Methods of immunomodulation in animals |
| 01/20/2010 | EP1204870B1 Method for determining physiological effects of hemoglobin |
| 01/20/2010 | EP0917538B1 Eukaryotic cells expressing at their surface at least an hla-g isoform and their applications |
| 01/20/2010 | CN101631555A Prophylactic agent for autoimmune disease |
| 01/20/2010 | CN101628014A Application of medicine combination in preparing preparation for treating chronic hepatitis B |
| 01/20/2010 | CN101628013A Bee product composition for improving human body immunity |
| 01/20/2010 | CN101628012A Medicine composition with function of regulating immunity and preparation method thereof |
| 01/20/2010 | CN101628011A Method for preparing embryo medicament by taking high-stability easily-absorbed protein polypeptide as raw material |
| 01/20/2010 | CN101628010A Immune agent for controlling and curing I type diabetes mellitus |
| 01/20/2010 | CN101628009A Gene therapy zinc-finger protease nucleic acid gene engineering medicine |
| 01/20/2010 | CN100582215C Megasphaera elsdenii strain and its uses |
| 01/20/2010 | CN100581583C Chinese traditional medicine for external application for treating children's lax |
| 01/20/2010 | CN100581582C Compound oral taking preparation of cantharis, and preparation method |
| 01/20/2010 | CN100581581C Technique for preparing Chinese traditional medicine and pills for clearing away heart-fire, dispersing phlegm, tranquilizing the mind, and reducing blood pressure |
| 01/20/2010 | CN100581580C Oral administration medicinal broth for treating pulmonary tuberculosis |
| 01/20/2010 | CN100581579C Medicinal composition for treating prostate disease and its preparation method and application |
| 01/20/2010 | CN100581578C Chinese traditional medicine capsule for healing neuropathic pain and preparing process technique thereof |
| 01/20/2010 | CN100581577C Thrombus diminishing blood-pressure reducing preparation |
| 01/20/2010 | CN100581576C Medicine for treating nonunion of bone and method for preparing the same |
| 01/20/2010 | CN100581575C Cervical spondylosis treating medicine and its preparation |
| 01/20/2010 | CN100581570C Traditional Chinese medicine decoction |
| 01/20/2010 | CN100581564C Yang-nourishing five-saponins medicine for preventing and curing cardiovascular or cerebrovascular disease, and the prepartion and the method for preparing the same |
| 01/20/2010 | CN100581558C Preparation of blood-activating and pain-stopping capsules |
| 01/20/2010 | CN100581555C Viable prebiotics bacteria microcapsule preparations for livestock and method for preparing the same |
| 01/20/2010 | CN100581554C Abalone shell calcium complement agent |
| 01/20/2010 | CN100581553C Diluent for preserving frozen red deer semen |
| 01/20/2010 | CN100581502C Human soft tissue filler for injection, and its preparation method |
| 01/19/2010 | US7648968 Using water insoluble microparticulate glucans comprising branched beta -(1,3)(1,6) glucan, essentially free of unbranched beta -(1,3)(1,6) glucan and non-glucan components |
| 01/19/2010 | US7648707 Compositions and methods for treatment of microbial infections |
| 01/19/2010 | CA2373255C Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
| 01/14/2010 | WO2010006260A1 Methods of use of eggshell polypeptides |
| 01/14/2010 | WO2010005557A2 Biological therapeutic compositions and methods thereof |
| 01/14/2010 | WO2010005532A1 Tumor-initiating cells and methods of use |
| 01/14/2010 | WO2010005527A1 Treatment of eye diseases and excessive neovascularization using a combined therapy |
| 01/14/2010 | WO2010005069A1 Immunity-inducing agent and method for detection of cancer |
| 01/14/2010 | WO2010005047A1 Intestinal environment-improving agent |
| 01/14/2010 | WO2010005012A1 Apolactoferrin-containing composition |
| 01/14/2010 | WO2010004525A1 Compositions containing a combination of propolis and a phenolic derivative and biological applications thereof |
| 01/14/2010 | WO2010004334A2 Exine shells |
| 01/14/2010 | WO2010003916A1 New probiotic bifidobacterium longum |
| 01/14/2010 | WO2010003279A2 A cryosurgery anticancer antigen preparation and its preparation method |
| 01/14/2010 | WO2009144569A3 Hydrogel capable of containing and conveying cells |
| 01/14/2010 | WO2009143453A3 Iga and igg for reducing lung inflammation in an animal |
| 01/14/2010 | US20100011454 Human artificial chromosome (hac) vector and human cell medicine comprising same |
| 01/14/2010 | US20100009440 Spore-like cells and uses thereof |
| 01/14/2010 | US20100008992 Treatment of disc degenerative disease and compositions for same |
| 01/14/2010 | US20100008979 Delivery of therapeutic agents to the bone |
| 01/14/2010 | US20100008977 Liposomally encapsulated hybrid adenovirus-semliki forest virus (sfv) vectors carrying rnai constructs and therapeutic genes for use against cancer targets and other diseases |
| 01/14/2010 | US20100008964 Isolated stromal cells and methods of using the same |
| 01/14/2010 | US20100008946 Microorganisms for therapy |
| 01/14/2010 | US20100008937 Targeted delivery to leukocytes using non-protein carriers |
| 01/14/2010 | US20100008920 Reagents and Methods for Engaging Unique Clonotypic Lymphocyte Receptors |
| 01/14/2010 | US20100008916 Inhibit inflammation for long periods without accompanying serious side effects in the drug therapy to patients with inflammatory bowel syndrome |
| 01/14/2010 | US20100008891 Production of Pluripotent Cells Through Inhibition of Bright/Arid3a Function |
| 01/14/2010 | US20100008890 MAPC Therapeutics Without Adjunctive Immunosuppressive Treatment |
| 01/14/2010 | US20100008889 Adenoviral expression vectors |
| 01/14/2010 | CA2730664A1 Methods of use of eggshell polypeptides |
| 01/14/2010 | CA2730088A1 Immunity-inducing agent and method for detection of cancer |
| 01/14/2010 | CA2730060A1 Exine shells |
| 01/14/2010 | CA2729633A1 Tumor-initiating cells and methods of use |
| 01/14/2010 | CA2729303A1 Treatment of eye diseases and excessive neovascularization using a combined therapy |
| 01/14/2010 | CA2728069A1 Means and methods for counteracting, delaying and/or preventing heart disease |
| 01/14/2010 | CA2670964A1 Use of composition for manufacture of medicant and method for inhibiting formation of body fat |
| 01/14/2010 | CA2637517A1 Cold storage of modified platelets |